Gene · 6118
Papers2,490
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,490
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Poly (ADP-ribose) polymerase inhibitor sensitized DNA damage caused by an alkylating pyrrole-imidazole polyamide targeting MYCN in neuroblastoma cells. | Biochem Biophys Res Commun | 2024 | 39395371 | PubTator, text mining | PubMed |
| Topological stress triggers persistent DNA lesions in ribosomal DNA with ensuing formation of PML-nucleolar compartment. | Elife | 2024 | 39388244 | PubTator, text mining | PubMed |
| AXL inhibition prevents RPA2/CHK1-mediated homologous recombination to increase PARP inhibitor sensitivity in hepatocellular carcinoma. | Heliyon | 2024 | 39281567 | PubTator, text mining | PubMed |
| Heterozygous RPA2 variant as a novel genetic cause of telomere biology disorders. | Genes Dev | 2024 | 39231615 | PubTator, text mining | PubMed |
| The effect of replication protein A inhibition and post-translational modification on ATR kinase signaling. | Sci Rep | 2024 | 39187637 | PubTator, text mining | PubMed |
| Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphoma. | Blood Adv | 2024 | 39167801 | PubTator, text mining | PubMed |
| Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation. | Mol Cancer Res | 2024 | 39083088 | PubTator, text mining | PubMed |
| Schlafen 11 further sensitizes BRCA-deficient cells to PARP inhibitors through single-strand DNA gap accumulation behind replication forks. | Oncogene | 2024 | 38961202 | PubTator, text mining | PubMed |
| Bloom syndrome DNA helicase mitigates mismatch repair-dependent apoptosis. | Biochem Biophys Res Commun | 2024 | 38850810 | PubTator, text mining | PubMed |
| 14-3-3σ downregulation sensitizes pancreatic cancer to carbon ions by suppressing the homologous recombination repair pathway. | Aging (Albany NY) | 2024 | 38843383 | PubTator, text mining | PubMed |
| CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity. | Sci Adv | 2024 | 38781342 | PubTator, text mining | PubMed |
| Mechanism of single-stranded DNA annealing by RAD52-RPA complex. | Nature | 2024 | 38658755 | PubTator, text mining | PubMed |
| Cytotoxicity and Multi-Enzyme Inhibition of Nepenthes miranda Stem Extract on H838 Human Non-Small Cell Lung Cancer Cells and RPA32, Elastase, Tyrosinase, and Hyaluronidase Proteins. | Plants (Basel) | 2024 | 38592804 | PubTator, text mining | PubMed |
| CSB and SMARCAL1 compete for RPA32 at stalled forks and differentially control the fate of stalled forks in BRCA2-deficient cells. | Nucleic Acids Res | 2024 | 38416570 | PubTator, text mining | PubMed |
| RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma. | iScience | 2024 | 38323009 | PubTator, text mining | PubMed |
| The chromatin-associated lncREST ensures effective replication stress response by promoting the assembly of fork signaling factors. | Nat Commun | 2024 | 38302450 | PubTator, text mining | PubMed |
| Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets. | Int J Mol Sci | 2024 | 38279263 | PubTator, text mining | PubMed |
| Human papillomavirus E7 protein induces homologous recombination defects and PARPi sensitivity. | J Cancer Res Clin Oncol | 2024 | 38263342 | PubTator, text mining | PubMed |
| STK19 is a DNA/RNA-binding protein critical for DNA damage repair and cell proliferation. | J Cell Biol | 2024 | 38252411 | PubTator, text mining | PubMed |
| NRF2 promotes radiation resistance by cooperating with TOPBP1 to activate the ATR-CHK1 signaling pathway. | Theranostics | 2024 | 38169561 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6118/papers?page=5